Cerner is leveraging its latest acquisition of Kantar Well being to create a brand new enterprise unit focusing on corporations conducting medical trials, the corporate introduced Tuesday.
Dubbed Enviza, the brand new division will promote knowledge and analysis companies to facilitate medical analysis carried out by life sciences companies. The unit will carry collectively Cerner’s knowledge enterprise with life sciences experience from Kantar Well being, which Cerner bought for $375 million through a deal that closed in April.
Enviza’s clients primarily might be life sciences corporations and healthcare suppliers, stated Mike Kelly, world head of Enviza and former president and chief working officer of Kantar Well being. Suppliers that take part in Cerner’s Studying Well being Community can entry the digital well being information database and analytics instruments for free of charge. Corporations creating new medicine and different therapies will present most of Enviza’s income, Kelly stated.
“Life sciences is keenly to have entry to the real-world knowledge,” Kelly stated. Life sciences corporations using Enviza’s knowledge and companies will have the ability to pace new therapies by means of the scientific and regulatory processes, he stated.
Download Modern Healthcare’s app to stay informed when industry news breaks.
Enviza will promote entry to de-identified affected person data from EHRs and provide analysis companies to pharmaceutical and biotechnology corporations. The brand new division is ready as much as assist purchasers gather related knowledge, arrange trials, and submit security and efficacy findings to regulators.
Cerner’s Studying Well being Community is the repository for anonymized affected person information collected from 76 taking part well being techniques. Enviza purchasers will have the ability to use these knowledge to find sufferers who could also be acceptable for medical trials. Enviza will then give Cerner’s supplier clients the choice to contact sufferers and invite them to take part in analysis research.
Digital well being information distributors akin to Cerner have sought to diversify their companies past promoting data expertise techniques by providing instruments and companies to assist suppliers and life sciences corporations make the most of affected person knowledge for his or her operations.
Cerner has identified “data-as-a-service” as a progress alternative. Previous to creating Enviza, the corporate put this into motion by creating the Studying Well being Community and investing in Elligo Health Research, a startup targeted on medical trials.
“Cerner is unquestionably monetizing the information sitting in its EHR platform,” stated Paddy Padmanabhan, CEO of Damo Consulting. “It is a massive frontier within the unlocking of affected person knowledge.”
Final 12 months, Epic Methods launched Cosmos, a database of de-identified EHR knowledge collected within the Epic Well being Analysis Community. Allscripts’ Veradigm payer and life sciences division additionally sells analytics instruments to suppliers and de-identified affected person knowledge for biopharma researchers.
Healthcare suppliers have made forays into comparable strains of enterprise that compile and promote affected person knowledge, as nicely. Ventures akin to hospital-backed Truveta have raked in millions of dollars in investments.
Cerner reported $1.5 billion in second-quarter revenue in July, up 9.5% from $1.3 billion from the year-ago interval, which the corporate recognized because the quarter most affected by the COVID-19 pandemic. Cerner’s working earnings for the second quarter of 2021 had been down 66% to $49.6 million, the corporate reported. Cerner is because of announce its third-quarter financials on Friday.
